The study explores the potential of chitosan derivatives as novel inhibitors against the wild-type and emerging variants of ...

Chitosan, a naturally occurring polysaccharide derived from chitin, has demonstrated significant potential as an antiviral ...

SARS-CoV-2 binds to the human cell receptor angiotensin-converting enzyme 2 (ACE2) through its receptor-binding domain in the S1 subunit of the spike protein (S1-RBD). The serum levels of ...

The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

For decades, lab-made antibodies have been used to support patients fighting specific diseases. These treatments have become ...

Trump has shut down the USAID work saying that it was not aligned with American strategic interests and wastes money.

An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

UNIGE scientists have developed a groundbreaking technology that creates synthetic molecules mimicking antibodies, potentially revolutionizing disease treatments.

As the pandemic rapidly spread to almost every corner of the world, immunologists worked to develop a vaccine that could handle the Coronavirus on a massiv ...

A new study from researchers at Weill Cornell Medicine-Qatar (WCM-Q) reveals how the SARS-CoV-2 virus evolved from initially ...

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with more rapid progression of coronary ...